Conduit Pharmaceuticals Inc.股价重挫25.44% 市值跌169.84万美元

市场透视12-23 22:35

北京时间2024年12月23日22时35分，Conduit Pharmaceuticals Inc.（CDT.us）股票出现异动，股价大幅下跌25.44%。截至发稿，该股报0.056美元/股，成交量646.142万股，换手率5.39%，振幅9.37%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.46百万美元，每股收益-0.07美元，毛利-5000.00美元，市盈率-0.24倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2493766178?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-23 22:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2493766178","market":"us","top_or_hot":-1,"title":"Conduit Pharmaceuticals Inc.股价重挫25.44% 市值跌169.84万美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月23日22时35分，Conduit Pharmaceuticals Inc.（CDT.us）股票出现异动，股价大幅下跌25.44%。截至发稿，该股报0.056美元/股，成交量646.142万股，换手率5.39%，振幅9.37%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.46百万美元，每股收益-0.07美元，毛利-5000.00美元，市盈率-0.24倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223539ab8e4220&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Conduit Pharmaceuticals Inc.股价重挫25.44% 市值跌169.84万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConduit Pharmaceuticals Inc.股价重挫25.44% 市值跌169.84万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-23 22:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223539ab8e4220&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月23日22时35分，Conduit Pharmaceuticals Inc.（CDT.us）股票出现异动，股价大幅下跌25.44%。截至发稿，该股报0.056美元/股，成交量646.142万股，换手率5.39%，振幅9.37%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.46百万美元，每股收益-0.07美元，毛利-5000.00美元，市盈率-0.24倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223539ab8e4220&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4121","symbol_name":"生命科学工具和服务","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223539ab8e4220&s=b","article_id":"2493766178","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223539ab8e4220&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2493766178","pubTimestamp":1734964539,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月23日22时35分，Conduit Pharmaceuticals Inc.股票出现异动，股价大幅下跌25.44%。截至发稿，该股报0.056美元/股，成交量646.142万股，换手率5.39%，振幅9.37%。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc 是一家临床阶段的专业生物制药公司，其成立的目的是促进领先生物制药公司优先考虑的尚未或现在的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4121":"生命科学工具和服务","CDT":"Conduit Pharmaceuticals Inc.","CDTTW":"Conduit Pharmaceuticals Inc."},"translate_title":"Conduit Pharmaceuticals Inc. stock plunges 25.44%, market value falls $1.6984 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDT":1,"CDTTW":1},"content_text":"北京时间2024年12月23日22时35分，Conduit Pharmaceuticals Inc.（CDT.us）股票出现异动，股价大幅下跌25.44%。截至发稿，该股报0.056美元/股，成交量646.142万股，换手率5.39%，振幅9.37%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-6.46百万美元，每股收益-0.07美元，毛利-5000.00美元，市盈率-0.24倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Conduit Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为673.30%、453.47%、306.76%，振幅较大的相关个股有Gt Biopharma, Inc.、Traws Pharma, Inc.、Rapt Therapeutics, Inc.，振幅分别为41.26%、39.04%、36.35%。Conduit Pharmaceuticals Inc.公司简介：Conduit Pharmaceuticals Inc 是一家临床阶段的专业生物制药公司，其成立的目的是促进领先生物制药公司优先考虑的尚未或现在的临床资产的开发和商业化，以开发满足患者未满足的医疗需求的药品。 该公司目前的开发产品线包括一种葡萄糖激酶激活剂，该药物已进入 II 期临床阶段，用于治疗葡萄膜炎、桥本甲状腺炎、早产和肾移植排斥反应等自身免疫性疾病。 该公司的开发产品线还包括一种有效的、不可逆的人类髓过氧化物酶（MPO）抑制剂，有可能治疗特发性男性不育症。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493766178"}